AngioDynamics, Inc. (ANGO)
USD 8.93
(-3.56%)
USD 8.93
(-3.56%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 303.91 Million | 338.75 Million | 316.21 Million | 291.01 Million | 264.15 Million | 359.48 Million |
| Cost of Revenue | 149.21 Million | 164.5 Million | 150.48 Million | 134.22 Million | 113.88 Million | 167.61 Million |
| Gross Profit | 154.69 Million | 174.24 Million | 165.73 Million | 156.78 Million | 150.27 Million | 191.87 Million |
| Operating Expenses | 252.41 Million | 192.92 Million | 183.94 Million | 171.75 Million | 164.3 Million | 165.33 Million |
| Selling, General and Administrative Expenses | 143.98 Million | 144.25 Million | 133.75 Million | 117.22 Million | 116.5 Million | 116.13 Million |
| Research and Development Expenses | 31.51 Million | 29.88 Million | 30.73 Million | 36.39 Million | 29.68 Million | 29.43 Million |
| Other Expenses | 76.92 Million | 18.79 Million | 19.45 Million | 18.13 Million | 18.12 Million | 19.77 Million |
| Cost and Expenses | 496.34 Million | 357.43 Million | 334.43 Million | 305.97 Million | 278.19 Million | 332.95 Million |
| Operating Income | -97.71 Million | -19.23 Million | -19 Million | -14.87 Million | -14.16 Million | 21.43 Million |
| Interest Expense | - | 2.7 Million | 688 Thousand | 861 Thousand | 907 Thousand | 5.09 Million |
| Income Tax Expense | -7.28 Million | -1.99 Million | -3.4 Million | -4.5 Million | -1.34 Million | -1.87 Million |
| Earnings before Tax | -191.63 Million | -54.43 Million | -29.94 Million | -36.05 Million | -167.13 Million | 59.46 Million |
| Net Income | -184.34 Million | -52.44 Million | -26.54 Million | -31.54 Million | -165.78 Million | 61.34 Million |
| Earnings Per Share Basic | -4.59 | -1.33 | -0.68 | -0.82 | -4.37 | 1.64 |
| Earnings Per Share Diluted | -4.59 | -1.33 | -0.68 | -0.82 | -4.37 | 1.64 |
| Weighted Average Shares Outstanding | 40.18 Million | 39.48 Million | 39 Million | 38.34 Million | 37.96 Million | 37.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.18 Million | 39.48 Million | 39 Million | 38.34 Million | 37.96 Million | 37.48 Million |
| Gross Margin | 0.51 | 0.51 | 0.52 | 0.54 | 0.57 | 0.53 |
| EBIT Margin | -0.05 | 0.03 | 0.03 | 0.04 | 0.04 | 0.27 |
| Profit Margin | -0.61 | -0.15 | -0.08 | -0.11 | -0.63 | 0.17 |
| EBITDA | -14.29 Million | 12.19 Million | 11.13 Million | -8.89 Million | -143.73 Million | 10.55 Million |
| Earnings Before Tax Margin | -0.32 | -0.06 | -0.06 | -0.05 | -0.05 | 0.06 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 303.91 Million | 70.98 Million | 75.18 Million | 79.07 Million | 78.67 Million | 338.75 Million |
| Cost of Revenue | 162.26 Million | 35.03 Million | 42.6 Million | 38.81 Million | 38.61 Million | 164.5 Million |
| Gross Profit | 141.65 Million | 35.94 Million | 32.57 Million | 40.26 Million | 40.06 Million | 174.24 Million |
| Operating Expenses | 175.49 Million | 41.74 Million | 44.17 Million | 46.97 Million | 49.79 Million | 192.92 Million |
| Selling, General and Administrative Expenses | - | 35.02 Million | 35.98 Million | 34.75 Million | 38.22 Million | - |
| Research and Development Expenses | - | 6.72 Million | 8.18 Million | 8.65 Million | 7.94 Million | - |
| Other Expenses | -1.07 Million | -259 Thousand | -238 Thousand | -32 Thousand | -288 Thousand | 18.79 Million |
| Cost and Expenses | 337.75 Million | 76.78 Million | 86.78 Million | 85.78 Million | 88.4 Million | 357.43 Million |
| Operating Income | -33.84 Million | -5.8 Million | -11.59 Million | -13.12 Million | 35.03 Million | -19.23 Million |
| Interest Expense | 1.61 Million | 567 Thousand | 394 Thousand | 534 Thousand | 119 Thousand | 2.7 Million |
| Income Tax Expense | -7.28 Million | -692 Thousand | -12 Million | 16.43 Million | -11.02 Million | -1.99 Million |
| Earnings before Tax | -191.63 Million | -14.14 Million | -199.74 Million | -12.61 Million | 34.86 Million | -54.43 Million |
| Net Income | -184.34 Million | -13.44 Million | -187.73 Million | -29.04 Million | 45.88 Million | -52.44 Million |
| Earnings Per Share Basic | - | -0.33 | -4.67 | -0.72 | 1.15 | - |
| Earnings Per Share Diluted | - | -0.33 | -4.67 | -0.72 | 1.15 | - |
| Weighted Average Shares Outstanding | 40.18 Million | 40.42 Million | 40.23 Million | 40.21 Million | 39.84 Million | 39.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.18 Million | 40.42 Million | 40.23 Million | 40.21 Million | 39.96 Million | 39.48 Million |
| Gross Margin | 0.47 | 0.51 | 0.43 | 0.51 | 0.51 | 0.51 |
| EBIT Margin | - | 0.01 | -0.05 | 0.08 | -0.61 | - |
| Profit Margin | -0.61 | -0.19 | -2.50 | -0.37 | 0.58 | -0.15 |
| EBITDA | - | 1.01 Million | -4.07 Million | 6.38 Million | -47.8 Million | - |
| Earnings Before Tax Margin | -0.11 | -0.08 | -0.15 | -0.17 | 0.45 | -0.06 |
PCTN
300539
6069
OPAL
GTHR
FMBRY